Latest News and Press Releases

The 2nd edition of the eurekAWARDS is launched! Luxembourg, Belgium, Monaco, and Paris, France – 3 July 2023: eureKARE, a pioneering company focused on financing and building next generation...

eureKING, premier SPAC européen de la santé dédié à la bioproduction, annonce la signature d'une option de vente pour l’acquisition potentielle de Skyepharma pour créer un nouveau leader européen de...

Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company’s unique offer...

Skyepharma, un CDMO (« Contract Development Manufacturing Organisation ») basé en France avec plus de 20 ans d'expertise en matière d'innovation et de développement, est un acteur reconnu dans les...

Skyepharma, a France-based CDMO with over 20 years of innovation and development expertise, is a renowned player in the global biopharma and consumer health industries. The company’s unique offer in...

eureKARE co-founds EonBio to revolutionize drug discovery with pioneering cell-free technology on a chip eureKARE announces EonBio as the second company to be supported by its Belgium biomedical...

eureKARE appoints Anne Lauvergeon as a new Board member Luxembourg, Belgium, and Paris, France – 8 February 2023: eureKARE, an innovative investment company for disruptive synthetic biology...

eureKARE welcomes Dirac Biosciences as first company into its biomedical start-up studio Innovative gene circuit technology has the potential to detect and treat cancerous and other diseased cells ...

eureKARE co-leads EUR 5 million seed investment in Biomemory which is advancing cutting-edge DNA-based data storage solutions Luxembourg, Belgium, and Paris, France – 28 November 2022: eureKARE...

eureKARE launches innovation-driven start-up studio in Monaco to apply synthetic biology in tackling critical environmental challenges Luxembourg, Belgium, and Paris, France – 15 November...